16 completed, 2 recruiting, 1 terminated, 1 unknown. 20 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 20 | Completed 16, Recruiting 2, Terminated 1, Unknown 1 |
| Phase 2 | 5 | Completed 3, Recruiting 1, Terminated 1 |
Follow Gallbladder Cancer: new trials by email Literature Review of Gallbladder Cancer trials Research Report on Gallbladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer BTC-Ag-T (ACH-AgT001), Cyclophosphamide and Fludarabine - Biliary Tract Neoplasms, Cholangiocarcinoma, Intrahepatic | Phase 1 | Recruiting | Shanghai Zhongshan Hospital | 18 | 2026-05-01 | 2026-05-29 |
| Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors MDX2001 - Biliary Tract Cancer, Breast Cancer | Phase 1 / Phase 2 | Recruiting | ModeX Therapeutics, An OPKO Health Company | 330 | 2024-06-12 | 2026-10-15 |
| To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors TT-00420, Combination Product: Atezolizumab, Combination Product: Nab-Paclitaxel - Advanced Solid Tumor, Cholangiocarcinoma | Phase 1 / Phase 2 | Completed | TransThera Sciences (Nanjing), Inc. | 84 | 2022-04-13 | 2025-06-12 |
| Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors TT-00420, Nab-Paclitaxel - Advanced Solid Tumor, Cholangiocarcinoma | Phase 1 / Phase 2 | Completed | TransThera Sciences (Nanjing), Inc. | 203 | 2021-03-14 | 2024-04-26 |
| T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System Recombinant Human Interleukin-2, HER2Bi-Armed T Cells - Esophageal Cancer, Gastric Cancer | Phase 1 | Unknown | Yi Miao | 6 | 2016-02-01 | 2016-01-25 |
| ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers Acelarin, Cisplatin - Biliary Tract Cancer, Gallbladder Cancer | Phase 1 | Completed | The Christie NHS Foundation Trust | 21 | 2016-01-01 | 2023-05-17 |
| Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer erlotinib hydrochloride, gemcitabine hydrochloride, oxaliplatin - Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 1 | Completed | Vanderbilt-Ingram Cancer Center | 28 | 2009-11-01 | 2017-07-02 |
| A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer Gemcitabine, Oxaliplatin, Sorafenib - Cholangiocarcinoma, Biliary Tract Cancer | Phase 1 / Phase 2 | Terminated | University of Miami | 9 | 2009-08-01 | 2018-01-03 |
| Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer fluorouracil, irinotecan hydrochloride, leucovorin calcium - Anal Cancer, Carcinoma of the Appendix | Phase 1 | Completed | Mayo Clinic | 7 | 2008-06-01 | 2017-05-25 |
| Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. PSMA/PRAME - Ovarian, Melanoma | Phase 1 | Completed | Mannkind Corporation | 12 | 2007-02-01 | 2010-08-03 |
| Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer capecitabine, carboplatin, epirubicin hydrochloride - Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 1 | Completed | University of Nebraska | 46 | 2004-10-01 | 2024-01-03 |
| Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer erlotinib hydrochloride, gemcitabine hydrochloride, oxaliplatin - Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 1 | Completed | UNC Lineberger Comprehensive Cancer Center | 23 | 2004-08-01 | 2012-03-07 |
| Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer gemcitabine hydrochloride, pemetrexed disodium - Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 1 / Phase 2 | Completed | Alliance for Clinical Trials in Oncology | 68 | 2004-01-01 | 2016-12-07 |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer TRICOM-CEA(6D) - Breast Cancer, Colorectal Cancer | Phase 1 | Completed | Michael Morse, MD | 14 | 2002-01-01 | 2014-09-08 |
| Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer motexafin gadolinium, radiation therapy - Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 1 | Completed | University of Pittsburgh | 1998-11-01 | 2016-01-18 | |
| Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas fluorouracil, gemcitabine hydrochloride, leucovorin calcium - Colorectal Cancer, Esophageal Cancer | Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 108 | 1998-08-01 | 2012-03-23 |
| Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer irinotecan hydrochloride, oxaliplatin - Anal Cancer, Colorectal Cancer | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 36 | 1998-04-01 | 2013-06-26 |
| Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer gemcitabine hydrochloride, polymerase chain reaction, immunohistochemistry staining method - Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 1 | Completed | City of Hope Medical Center | 16 | 1997-12-01 | 2015-06-08 |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen Recombinant Interleukin-12 - Anal Cancer, Colorectal Cancer | Phase 1 | Completed | M.D. Anderson Cancer Center | 29 | 1997-08-01 | 2012-07-30 |
| Biological Therapy in Treating Patients With Metastatic Cancer CEA RNA-pulsed DC cancer vaccine - Breast Cancer, Colorectal Cancer | Phase 1 | Completed | Duke University | 24 | 1997-02-01 | 2013-02-22 |
Gallbladder Neoplasms (20) · Pancreatic Neoplasms (13) · Stomach Neoplasms (12) · Bile Duct Neoplasms (11) · Liver Neoplasms (11) · Colonic Neoplasms (7) · Biliary Tract Neoplasms (6) · Carcinoma, Hepatocellular (6) · Cholangiocarcinoma (6) · Colorectal Neoplasms (6) · Esophageal Neoplasms (6) · Rectal Neoplasms (6) · Small Cell Lung Carcinoma (5) · Anus Neoplasms (4) · Breast Neoplasms (4)
Biliary Tract Diseases (20) · Digestive System Diseases (20) · Digestive System Neoplasms (20) · Gallbladder Diseases (20) · Neoplasms (20) · Neoplasms by Site (20) · Endocrine Gland Neoplasms (15) · Endocrine System Diseases (15) · Biliary Tract Neoplasms (14) · Neoplasms by Histologic Type (14) · Neoplasms, Glandular and Epithelial (14) · Adenocarcinoma (13) · Carcinoma (13) · Gastrointestinal Diseases (13) · Gastrointestinal Neoplasms (13)
Gemcitabine (6) · Oxaliplatin (4) · Radiotherapy (3) · Erlotinib Hydrochloride (2) · Fluorouracil (2) · Irinotecan (2) · Leucovorin (2) · 130-nm albumin-bound paclitaxel (1) · Amplified Fragment Length Polymorphism Analysis (1) · Capecitabine (1) · Carboplatin (1) · Cisplatin (1) · Cyclophosphamide (1) · Epirubicin (1) · Immunohistochemistry (1)
TransThera Sciences (Nanjing), Inc. (2) · Alliance for Clinical Trials in Oncology (1) · City of Hope Medical Center (1) · Duke University (1) · M.D. Anderson Cancer Center (1) · Mannkind Corporation (1) · Mayo Clinic (1) · Memorial Sloan Kettering Cancer Center (1) · Michael Morse, MD (1) · ModeX Therapeutics, An OPKO Health Company (1) · National Institutes of Health Clinical Center (CC) (1) · Shanghai Zhongshan Hospital (1) · The Christie NHS Foundation Trust (1) · UNC Lineberger Comprehensive Cancer Center (1) · University of Miami (1)
United States (15) · China (3) · United Kingdom (1)
Herbert K. Lyerly, MD (2) · Bert H. O'Neil, MD (1) · Eva Szabo, MD (1) · Guoming Shi, MD, PhD (1) · Jean L Grem, MD (1) · Laura Goff, MD (1) · Nancy E. Kemeny, MD (1) · Peter Hosein, MD (1) · Ramesh K. Ramanathan, MD (1) · Renato Lenzi, MD (1) · Robert McWilliams, MD (1) · Sarina A. Piha-Paul, MD (1) · Stephen I. Shibata, MD (1) · Steven R. Alberts, MD (1)
PMID 12196376, PMID 19023677, PMID 33210382, PMID 41495607
2015 (1), P30CA015083 (1), P30CA016086 (1), P30CA016672 (1), P30CA033572 (1), P30CA036727 (1), P30CA068485 (1), R21CA094523 (1)